Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cellerix

Cellerix
2004 FOUNDED
M&A STATUS
61-70 EMPLOYEES
M&A LATEST DEAL TYPE
$79.7M LATEST DEAL AMOUNT
Description

Developer of medicinal products. The company's products are used for the treatment of gastroenterology, dermatology and immune-based diseases.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Therapeutic Devices
Acquirer
Primary Office
  • Madrid
  • Spain
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cellerix’s full profile, request a free trial.

Cellerix Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 05-May-2011 $79.7M 00000 000.00 Completed Generating Revenue
4. Debt - General 00000 Completed Generating Revenue
3. Later Stage VC 28-Jan-2010 000.00 00000 Completed Generating Revenue
2. Early Stage VC 11-Nov-2009 $40.2M $71.1M Completed Startup
1. Early Stage VC 01-Sep-2007 $30.9M $30.9M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cellerix Former Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Genetrix Group Corporation Minority 000 0000 000000 0
Life Sciences Partners Venture Capital Minority 000 0000 000000 0
Novartis Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Roche Venture Fund Corporate Venture Capital Minority 000 0000 000000 0
Ventech Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »